Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
John Spertus
Duke University, Department: Biostatistics & Other Math Sci
Should you be removed from our database? Contact us at [email protected]. Read more below.
CV Outcomes
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Spertus is a founder and President of CV Outcomes, he also owns the copyright o the Seattle Angina Questionnaire (SAQ) which is being distributed to this trial through CV Outcomes.
ISCHEMIA-CKD SDCC
PROJECT NARRATIVE This trial will inform clinicians and patients about a common question they encounter: when a patient with advanced chronic kidney disease has a markedly abnormal cardiac stress test: is it better to do an invasive angiogram (take a picture of the heart arteries) with the intention of opening or bypassing any blockages with stents or surgery plus optimal medical therapy, or is it better to optimize medical therapy and only consider the angiogram with stents or surgery if symptoms cannot be controlled? If there is a benefit to doing an angiogram and treating with stents or surgery, then clinicians and patients must be made aware of these benefits and put them into practice to prevent bad outcomes like heart attacks and death; if the results show there is no benefit or there is harm from that routine invasive testing, then treatment would begin with only intensive lifestyle change and medication to control symptoms and reduce risk. Either finding could provide much-needed information to guide practice and improve quality of medical care.
Filed on October 23, 2013.
Tell us what you know about John Spertus's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “John Spertus”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| John Spertus | Duke University | Conflict of Interest | CV Outcomes | Value cannot be readily determined |
| John Spertus | Duke University | Conflict of Interest | CV Outcomes | Value cannot be readily determined |
| John Spertus | Duke University | Conflict of Interest | CV Outcomes | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.